对160例糖尿病前期伴CHF及Ualb异常患者,应用瑞彤治疗6个月,治疗前后检测体重指数(BMI)、腰臀比(WHR)、空腹血糖(FPG)、餐后2小时血糖(2hPG)、胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C),空腹胰岛素(FINS)、Ualb、CHFNYHA分级,6分钟步行试验,超声心动图(UCG)检查评价左心室舒缩功能。结论:瑞彤在改善胰岛素抵抗(IR),降低FPG、PG,调节脂代谢紊乱的同时,对改善心脏舒缩功能,减少UA1b有效。 The patients with abnormal pre-diabetes with CHF and Ualb abnormalities were treated with Ruitong for 6 months before and after treatment. Body mass index (BMI), WHR, fasting blood glucose (FPG), 2-hour postprandial blood glucose (2hPG) (TC), triglyceride (TG), LDL-C, HDL-C, FINS, Ualb, CHFNYHA and 6-minute walk test , Echocardiography (UCG) examination to assess left ventricular systolic function. CONCLUSION: Ruitong can improve cardiac contractile function and reduce UA1b while improving insulin resistance (IR), reducing FPG and PG, regulating lipid metabolism disorder.